Rezultati - Yoshiko Takeda‐Uchimura
- Showing 1 - 2 results of 2
-
1
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology od Zui Zhang, Yoshiko Takeda‐Uchimura, Tahmina Foyez, Shiori Ohtake‐Niimi, Narentuya, Hiroyasu Akatsu, Kazuchika Nishitsuji, Makoto Michikawa, Tony Wyss‐Coray, Kenji Kadomatsu, Kenji Uchimura
Izdano 2017Artigo -
2
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease od Markus Britschgi, Christopher E. Olin, Hudson Johns, Yoshiko Takeda‐Uchimura, Melburne C. LeMieux, Kaspar Rufibach, Jayakumar Rajadas, H. Zhang, Beren H. Tomooka, William H. Robinson, Christopher M. Clark, Anne M. Fagan, Douglas Galasko, David M. Holtzman, Marek Jutel, Jeffrey Kaye, Cynthia A. Lemere, Jerzy Leszek, G. Li, Elaine R. Peskind, Joseph F. Quinn, Jerome A. Yesavage, Jorge Ghiso, Tony Wyss‐Coray
Izdano 2009Artigo
Iskalna orodja:
Sorodne teme
Alzheimer's disease
Amyloid (mycology)
Biochemistry
Biology
Chemistry
Disease
Immunology
Medicine
Pathology
Amyloid precursor protein
Antibody
Cerebrospinal fluid
Environmental health
Extracellular matrix
Glycan
Glycoprotein
Inflammation
Inorganic chemistry
Internal medicine
Keratan sulfate
Microglia
Neuroprotection
Peptide
Pharmacology
Population
Proteoglycan
Receptor
SIGLEC
Sialic acid
TREM2